ÂÜÀòÂÒÂ×

Melvin Toh serves as Vice President and Chief Scientific Officer at CK Life Sciences, where responsibilities include technology and product development with a focus on pharmaceuticals, medical devices/diagnostics, and healthcare services. Prior experience includes roles at Pfizer, such as Vice President of Pharmaceutical Development, Vice President of Clinical & Regulatory Affairs, Director of Clinical Pharmacology in Oncology Development, Medical Director at the Pfizer Clinical Research Unit in Singapore, and Regional Pharmacovigilance Manager. Earlier career experience includes serving as a Medical Monitor at Quintiles East Asia. Melvin Toh holds an MBBS degree in Medicine from the National University of Singapore and an MSc in Epidemiology from the University of London.